Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor γ and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population

Journal of Biosciences

Volumn 34, Issue 3, 2009, Pages 405-414

  Haseeb, Abdul ^a   Iliyas, Mohammad ^a   Chakrabarti, Subhabrata ^b   Farooqui, Arif A ^c   Naik, Sudhir R ^c   Ghosh, Sudip ^a   Suragani, Madhuri ^a   Ehtesham, Nasreen Z ^a  

^a NATIONAL INSTITUTE OF NUTRITION   (India)

^b L V PRASAD EYE INSTITUTE   (India)

^c Mediciti Hospitals   (India)

Author keywords

C1431T; India; Metabolic syndrome; Pro12Ala; Resistin

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN;

AGED; ALLELE; ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; GENE FREQUENCY; GENETICS; GEOGRAPHY; HAPLOTYPE; HUMAN; INDIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; COHORT STUDIES; FEMALE; GENE FREQUENCY; GEOGRAPHY; HAPLOTYPES; HUMANS; INDIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; PREVALENCE; RESISTIN;

EID: 73449137637     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-009-0047-x     Document Type: Article

References (39)

1. Alberti K G and Zimmet P Z 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation; Diabet. Med. 15 539-553
2. Altshuler D, Hirschhorn J N, Klannemark M, Lindgren C M, Vohl M C, Nemesh J, Lane C R, Schaffner S F et al. 2000 The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes; Nat. Genet. 26 76-80
3. Barrett J C, Fry B, Maller J and Daly M J 2005 Haploview: analysis and visualization of LD and haplotype maps; Bioinformatics 21 263-265
4. Deeb S S, Fajas L, Nemoto M, Pihlajamaki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W et al. 1998 A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity; Nat. Genet. 20 284-287
5. Doney A, Fischer B, Frew D, Cumming A, Flavell D M, World M, Montgomery H E, Boyle D et al. 2002 Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight; BMC Genet. 3 21-28
6. Doney A S, Fischer B, Cecil J E, Boylan K, McGuigan F E, Ralston S H, Morris A D and Palmer C N 2004 Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes; Diabetologia 47 555-558
7. Dongxia L, Qi H, Lisong L and Jincheng G 2008 Association of peroxisome proliferator-activated receptor gamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome; Circ. J. 72 551-557
8. Ek J, Urhammer S A, Sorensen T I, Andersen T, Auwerx J and Pedersen O 1999 Homozygosity of the Pro12Ala variant of the peroxisome proliferation activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men; Diabetologia 42 892-895
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III); JAMA 285 2486-2497
10. Frederiksen L, Brodbaek K, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S and Urhammer S A 2002 Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome; J. Clin. Endocrinol. Metab. 87 3989-3992
11. Ghosh S, Singh A K, Aruna B, Mukhopadhyay S and Ehtesham N Z 2003 The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications; Gene 305 27-34
12. Hivert M F, Sullivan L M, Fox C S, Nathan D M, D'Agostino R B Sr, Wilson P W and Meigs J B 2008 Association of adiponectin, resistin and TNF{alpha} with insulin resistance; J. Clin. Endocrinol. Metab. 93 3165-3172
13. Kliewer S A, Lenhard J M, Willson T M, Patel I, Morris D C and Lehmann J M 1995 A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation; Cell 83 813-819
14. Meirhaeghe A, Cottel D, Amouyel P and Dallongeville J 2005 Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women; Diabetes 54 3043-3048
15. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J et al. 1998 A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans; Hum. Mol. Genet. 7 435-440
16. Misra A and Vikram N K 2004 Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications; Nutrition 20 482-491
17. Montagnana M, Fava C, Nilsson P M, Engström G, Hedblad B, Lippi G, Minuz P, Berglund G et al. 2008 The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals; Diabet. Med. 25 902-908
18. Mori Y, Kim-Motoyama H, Katakura T, Yasuda K, Kadowaki H, Beamer B A, Shuldiner A R, Akanuma Y et al. 1998 Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men; Biochem. Biophys. Res. Commun. 251 195-198
19. Nagaev I and Smith U 2001 Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle; Biochem. Biophys. Res. Commun. 285 561-564
20. Oh E Y, Min K M, Chung J H, Min Y K, Lee M S, Kim K W and Lee M K 2000 Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects; J. Clin. Endocrinol. Metab. 85 1801-1804
21. Patel L, Buckels A C, Kinghorn I J, Murdock P R, Holbrook J D, Plumpton C, Macphee C H and Smith S A 2003 Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators; Biochem. Biophys. Res. Commun. 300 472-476
22. Radha V, Vimaleswaran K S, Babu H N, Abate N, Chandalia M, Satija P, Grundy S M, Ghosh S et al. 2006 Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: evidence for heterogeneity; Diabetes Care 29 1046-1051
23. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das A K, Rao P V and Yajnik C S and Diabetes Epidemiology Study Group in India (DESI) 2001 High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey; Diabetologia 44 1094-1101
24. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S and Vijay V 2003 Metabolic syndrome in urban Asian Indian adults - a population study using modified ATP III criteria; Diabetes Res. Clin. Pract. 60 199-204
25. Rhee E J, Oh K W, Lee W Y, Kim S Y, Oh E S, Baek K H, Kang M I and Kim S W 2006 Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome; Arch. Med. Res. 37 86-94
26. Ristow M, Müller-Wieland D, Pfeiffer A, Krone W and Kahn C R 1998 Obesity associated with a mutation in a genetic regulator of adipocyte differentiation; N. Engl. J. Med. 339 953-959
27. Scacchi R, Pinto A, Rickards O, Pacella A, De Stefano G F, Cannella C and Corbo R M 2007 An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits; Nutr. Metab. Cardiovasc. Dis. 17 632-641
28. Sicree R, Shaw J and Zimmet P 2006 Diabetes and impaired glucose tolerance; in Diabetes atlas 3rd edition (ed.) D Gan (Belgium: International Diabetes Federation) pp 15-103
29. Silswal N, Singh A K, Aruna B, Mukhopadhyay S, Ghosh S and Ehtesham N Z 2005 Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway; Biochem. Biophys. Res. Commun. 334 1092-1101
30. Snehalatha C, Viswanathan V and Ramachandran A 2003 Cutoff values for normal anthropometric variables in Asian Indian adults; Diabetes Care 26 1380-1384
31. Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S et al. 2001 The hormone resistin links obesity to diabetes; Nature (London) 409 307-312
32. Stumvoll M and Haring H 2002 The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism; Diabetes 51 2341-2347
33. Tai E S, Corella D, Deurenberg-Yap M, Adiconis X, Chew S K, Tan C E and Ordovas J M 2004 Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population; J. Lipid Res. 45 674-685
34. Tontonoz P, Hu E, Devine J, Beale E G and Spiegelman B M 1995 PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene; Mol. Cell. Biol. 15 351-357
35. Valve R, Sivenius K, Miettinen R, Pihlajamaki J, Rissanen A, Deeb S S, Auwerx J, Uusitupa M et al. 1999 Two polymorphisms in the peroxisome proliferator activated receptor-gamma gene are associated with severe overweight among obese women; J. Clin. Endocrinol. Metab. 84 3708-3712
36. Vimaleswaran K S, Radha V, Deepa R and Mohan V 2007 Absence of association of metabolic syndrome with PPARGC1A, PPARG and UCP1 gene polymorphisms in Asian Indians; Metab. Syndr. Relat. Disord. 5 153-162
37. Wang C, Zhai F, Chi Y and Wang G 2004 Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population; Wei Sheng Yan Jiu. 33 317-320
38. Way J M, Görgün C Z, Tong Q, Uysal K T, Brown K K, Harrington W W, Oliver W R Jr, Willson T M et al. 2001 Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists; J. Biol. Chem. 276 25651-25653
39. Zimmet P, Magliano D, Matsuzawa Y, Alberti G and Shaw J 2005 The metabolic syndrome: a global public health problem and a new definition; J. Atheroscler. Thromb. 12 295-300